Skip to main content

C.R. Bard Lawsuits Selected For Second Bellwether Trial

C.R. Bard Lawsuits Selected For Second Bellwether Trial

C.R. Bard Lawsuits Selected For Second Bellwether Trial

Introduction

In a case management order issued on June 28, Judge David Campbell presiding over the established Bard IVC filter MDL confirmed three lawsuits as the next bellwether trials. The trials are scheduled for September 2018, November 2018, and February 2019, respectively.

The first bellwether trial against Bard concluded with a $3.6 million verdict favoring the plaintiff while the jury sided with the defendant in the second bellwether trial on June 1, 2018. Lawsuits claim blood clot filters sold by C.R. Bard are defectively designed and tend to rupture and injure internal organs.

More than 3,500 Bard IVC lawsuits are filed against the manufacturer, which were centralized as part of a multidistrict litigation (MDL No. 2641; In Re: Bard IVC Filters Products Liability Litigation) on August 17, 2015, in the U.S. District Court District of Arizona. The outcome of these bellwether trials will be closely observed by other parties involved in the litigation for proceeding with eventual settlement negotiations.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Talcum Powder Cancer Settlement Talks Begin Sept. 4

Categories: Talcum

Representatives of Johnson & Johnson (J&J) and attorneys for tens of thousands of plaintiffs involved in talcum powder lawsuits are scheduled to meet in September 2025 in an…

Tepezza Hearing Loss Trials Delayed Until Aug 2026

Categories: Tepezza

A series of Tepezza hearing loss lawsuits, which were expected to go before juries next year, will now be delayed. The U.S. District Judge overseeing the multidistrict…

Cencora Directors Settle Opioid Oversight Case for $111M

Categories: Opioids

Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!